 REDWOOD CITY, Calif., Nov. 10, 2020 GLOBE NEWSWIRE -- Pulmonx Corporation Nasdaq: LUNG Pulmonx, a commercial-stage medical technology company that provides minimally invasive treatment for patients with severe emphysema, a form of COPD, today reported financial results for the third quarter ended September 30, 2020. 